Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
about
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adultsNew directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityEltrombopag for the treatment of aplastic anemia: current perspectivesA prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationRecent advances in treatment of aplastic anemia.Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigensCTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model.Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia.Clinical management of aplastic anemia.Graft-versus-host disease prophylaxis after transplantation: a network meta-analysis.Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisAllogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders.Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.Aplastic anemia: pathophysiology and treatment.Success of allogeneic marrow transplantation for children with severe aplastic anaemia.Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the EurTransfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice.Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant.Acquired aplastic anemia in children.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation.Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review.How I manage aplastic anaemia in children.Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.The diagnosis and treatment of aplastic anemia: a review.Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations.Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
P2860
Q24200813-86135824-3722-4B88-B25E-73CB24897518Q26823090-784BE22D-84FC-4A3A-B268-188F3AE1FA33Q28071710-1FA38333-1985-45BA-B9A5-3147DA8D1D4DQ33573529-EA063F9A-8F75-4A49-8628-59E4A661BDAEQ34451351-275BA1B7-0A0A-4FF0-AF42-EF6B6B174C30Q34824419-EC73B033-931E-4432-8C48-694B343EB588Q34824540-CFD79050-F96D-4A83-82BF-A9E85F6C374DQ34976550-F0F525D0-91E7-4330-9078-BEA217CB3EFAQ35110555-87546F5D-2579-41DC-BD8E-F9F61A47E3EAQ35112372-F68BFD5A-5B76-4DB5-A06F-F4B811C2A8FCQ35499395-00880B2C-5B1D-4387-805A-F1127B0DEB57Q35571068-A27D786B-453E-4977-9797-C41BE8253BBEQ35909475-09032E62-3E71-4E21-8038-3E1E2282E476Q36055158-8D0BFAAD-6829-43D4-9C00-1F37632D5FBCQ36120565-D34DB331-5874-4C0D-82B2-A0857DF95976Q36133000-3ED8A859-CE44-4D0C-AF8A-F70B1A12B482Q36464602-3ADAFB2A-091F-4922-A461-3BCE78E517BFQ36958013-4FBC5F35-B70E-4EDB-98E5-D8161E482635Q37081469-D8409934-E35A-44EC-9CB2-3C9982F0DA67Q37216096-8EB27C30-0D09-4A67-9CBD-C11B4EC5799BQ37273222-7B6504F1-9433-4859-9AB2-B3686D89CC84Q37328417-7549721F-DEDF-4E45-A35C-13F1F61519B4Q37334992-9CC6FF2F-3A8D-44BF-9D5D-125CCF76F342Q37351058-2F0277BA-2862-4AB6-9787-480EF3CFEC8EQ37482272-877364E8-8D19-4767-B2D3-BBC7BD5E4FE7Q37490182-E12A9192-E28D-4827-9E0C-5416D6CDD66FQ37490754-9A367C53-E7F4-4F0B-AC34-FC8CF1A8EAA8Q37618811-529CF204-D724-4CE0-A8A6-0079C71F69CAQ37706850-F2B9A13B-90DD-4F14-9638-BBA5A11B2452Q37770210-51AC2BFB-6358-4C40-99D5-817A66A2297BQ37776637-DA70859C-4963-42F8-811E-DD1CE02DA398Q37969888-FD394B06-2FF9-4DEF-B684-DC6DF4372EE1Q37986162-55A51188-460D-4213-8D0F-C40A2C6748D2Q38061041-25812DBB-732A-47B8-947A-4C5BC688DF69Q38103184-198C02B6-E33D-4D32-B71F-321C7DF4E88CQ38261555-313C3D94-B905-44FD-A787-C0BF3BDF08FDQ38402936-612411D2-3F42-4741-9B5B-9E7A4A9ECB4DQ38728525-9D0C144D-927B-41F6-8C96-6CAC10592677Q38773356-47F626C5-9E28-4677-9697-D93E59D8047DQ39036486-87028014-85A3-4988-8B6D-C6EDB64B347C
P2860
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bone marrow transplantation fo ...... study of conditioning regimens
@ast
Bone marrow transplantation fo ...... study of conditioning regimens
@en
type
label
Bone marrow transplantation fo ...... study of conditioning regimens
@ast
Bone marrow transplantation fo ...... study of conditioning regimens
@en
prefLabel
Bone marrow transplantation fo ...... study of conditioning regimens
@ast
Bone marrow transplantation fo ...... study of conditioning regimens
@en
P2093
P2860
P1433
P1476
Bone marrow transplantation fo ...... study of conditioning regimens
@en
P2093
Bruce M Camitta
Christopher N Bredeson
John P Klein
Mary Eapen
Mary M Horowitz
Richard E Champlin
Waleska S Perez
P2860
P304
P356
10.1182/BLOOD-2006-10-052308
P407
P577
2007-02-01T00:00:00Z